Breast Cancer
News
Despite Guidelines, Elderly Are Getting Cancer Tests
Major Finding: Among study subjects aged 75-79 years, 62% were screened for breast cancer, 53% for cervical cancer, 57% for colorectal cancer, and...
News
Early Oophorectomy Linked to Osteoporosis, Arthritis
Major Finding: The age-standardized mean femoral neck bone density was significantly lower in women with oophorectomy before age 45 than in those...
News
Statin Treatment Does Not Alter Breast Density
Major Finding: Treatment with atorvastatin did not significantly change mammographic breast density after 1 year. Data Source: A randomized phase...
News
Contralateral Prophylactic Mastectomy Ups Surgical Risk
Major Finding: Unilateral breast cancer patients undergoing contralateral prophylactic mastectomy were 1.5 times more likely to experience...
News
Breast Cancer Vaccine Begins Phase III Trial
Major Finding: Disease-free survival at a median follow-up of 5 years was 95.9% in breast cancer patients who received the E75 vaccine with twice-...
News
Axillary Dissection Often Unnecessary in Early Breast Cancer
Major Finding: The 5-year disease-free survival rate among breast cancer patients with minimal sentinel node involvement was 88.4% of women who...
News
AVEREL: Avastin Defers Progression in HER2-Positive Metastatic Breast Cancer*
Major Finding: In an assessment conducted by investigators, bevacizumab significantly improved progression-free survival when added to standard...
Conference Coverage
ZO-FAST: Immediate Zoledronic Acid Beats Delayed Tx in Early Breast Cancer
Major Finding: Immediate treatment with zoledronic acid reduced recurrence and mortality risk by 34% and 31%, respectively, and improved bone...
News
Clodronate Offered Modest Benefit for Breast Cancer Patients
Major Finding: Disease-free survival (DFS) did not differ between women treated with clodronate and those given placebo (hazard ratio, 0.91; P = ....
News
DCIS Assay Predicts Recurrence Risk After Breast Surgery
Major Finding: Twelve percent of patients with a low DCIS risk score experienced a disease recurrence within 10 years of breast-conserving surgery...
News
Dual HER2 Blockade Defers Breast Cancer Progression
Major Finding: Adding pertuzumab to a standard chemotherapy regimen of trastuzumab and docetaxel led to an additional 6 months of progression-free...